Frequently asked questions
Where are Novartis shares traded?
Novartis shares are listed and traded on the SIX Swiss Exchange (Valor No. 001200526, ISIN CH0012005267, symbol: NOVN.VX) as well as on the NYSE in the form of American Depositary Receipts (ADR) (Valor No. 567514, ISIN US66987V1098, symbol: NVS).
What are the ticker symbols for Novartis?
(Reuters / Bloomberg)
(Reuters / Bloomberg)
Shares NOVN.VX / NOVN VX ADRs NVS / NVS US
What is an ADR/ADS?
ADR stands for American Depositary Receipt. ADS stands for American Depositary Share. An ADR is a receipt for a number of shares of a foreign-based corporation held by a US depositary bank, entitling the ADR holder to all dividends and capital gains.
What is the number of outstanding shares in Novartis?
Key Novartis share data
(calculated on average number of shares outstanding)
2013 2012 Issued shares 2 706 193 000 2 706 193 000 Treasury shares1 280 108 692 285 572 826 Outstanding shares at December 31 2 426 084 308 2 420 620 174 Average number of shares outstanding 2 440 849 805 2 418 145 330
- Approximately 149 million treasury shares (2012: 1175 million) are held in entities that limit their availability for use.
What is the number of outstanding ADRs in Novartis?
Key data on US American Depositary Receipts (ADR) issued in the US
2013 2012 Year-end ADR price (USD) 80.38 63.30 ADRs outstanding1 317 193 803 315 795 416
- The depositary, JP Morgan Chase Bank, holds one Novartis AG share for every American Depositary Receipt (ADR) issued.
- Where can I find historical data for Novartis shares?
Can I deposit Novartis shares free of charge?
For residents of Switzerland you can deposit them through SIX SAG.
What is SIX SAG?
SIX SAG is an affiliate company of the SIX Group AG. Its business activities include share register and deposit administration as well as the organization and staging of shareholder meetings. For additional information, please contact:
Novartis Direct Share Purchase Plan
c/o SIX SAG Ltd
+41 58 399 61 99
+41 58 499 61 98
What is the date of your Annual General Meeting?
The 2014 Annual General Meeting was held on February 25, 2014 in Basel, Switzerland.
The Annual General Meeting 2015 will take place on February 27, 2015 in Basel, Switzerland.
When was your dividend paid in 2014?
The dividend payment date was set for March 4, 2014.
What is the dividend history for Novartis shares?
The Novartis dividend has increased steadily since 1996.
The Board proposes a 6% increase in the dividend payment for 2014 to CHF 2.60 per share (2013: CHF 2.45) for approval at the AGM on February 27, 2015.
This represents the 18th consecutive increase in the dividend paid per share since the creation of Novartis in December 1996. If the 2014 dividend proposal is approved by shareholders, dividends to be paid out will amount to approximately USD 6.4 billion (2013: USD 6.8 billion), resulting in an expected payout ratio of 63% of net income attributable to Novartis shareholders (2013: 74%).
Based on the 2014 year-end share price of CHF 92.35, the dividend yield will be 2.8% (2013: 3.4%). The dividend payment date has been set for March 5, 2015.
- How can I obtain the minutes of the last Annual General Meeting?
General Financial Questions
How do you calculate your earning per share?
Basic earnings per share (EPS) is calculated by dividing net income attributable to shareholders of Novartis AG by the weighted average number of shares outstanding in a reporting period. This calculation excludes the average number of issued shares purchased by the Group and held as treasury shares.
Basic earnings per share
Weighted average number of shares outstanding (in millions)
2,441 2,418 Net income attributable to shareholders of Novartis AG (USD millions) 9,175 9,270 Basic earnings per share (USD ) 3.76 3.83
1. Restated to reflect the adoption of revised IAS19 on Employee Benefits (see Annual report 2013 Note 30).
Novartis shares are widely held. As of December 31, 2013, Novartis had approximately 155 000 shareholders (2012: 161 000) listed in its share register, representing 73% of issued shares. Based on the Novartis AG share register and excluding treasury shares held by Novartis AG and its subsidiaries (excluding foundations), approximately 41% (2012: 42%) of the shares registered by name were held in Switzerland and 47% were held in the US (2012: 46%). Approximately 12% of the shares registered in the share register were held by individual investors, while 88% were held by legal entities, nominees, fiduciaries and the ADS depositary.
Are there any limitations on voting rights for registered shareholders?
The Company’s Articles of Incorporation state that no person or entity shall be registered with the right to vote for more than 2% of the share capital as set forth in the Commercial Register. In particular cases the Board of Directors may allow exemptions fromthe limitation for registration in the share register.
According to the share register, shareholders owning 2% or more of the Company’s capital at December 31, excluding treasury shares held by Novartis AG and other Novartis subsidiaries, are as follows:
% holding of share capital
December 31, 2013
% holding of share capital
December 31, 2012
Novartis Foundation for Employee Participation, Basel 3.0 4.0 Emasan AG, Basel 3.3 3.3
When does the fiscal year end for Novartis?
Novartis uses the 12-month calendar year, ending December 31, as its fiscal year.
- Where can I find historical financial information about Novartis?
What is the exposure to exchange rate risk for Novartis?
Novartis transacts business in many currencies. As a result of the Group’s foreign currency exposure, exchange rate fluctuations have a significant impact on its income statement, in the form of both translation risk and transaction risk.
Translation risk is the risk that the Group’s consolidated financial statements for a particular period may be affected by changes in the prevailing rates of the various currencies of the reporting subsidiaries.
Transaction risk is the risk that the currency impact of transactions executed in currencies other than the subsidiary currency may vary according to currency fluctuations.
Recent data for selected currencies is available in our Selected exchange rate data page.
What accounting convention does Novartis follow?
The Novartis Group (Group or Novartis) consolidated financial statements are prepared in accordance with the International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). They are prepared I accordance with the historical cost convention except for items that are required to be accounted for at fair value.
The preparation of financial statements requires management to make certain estimates and assumptions either at the balance sheet date or during the year that affect the reported amounts of assets and liabilities (including any contingent amounts) as well as revenues and expenses. Actual outcomes and results could differ from those estimates and assumptions.
- How can I get a copy of your Annual Report?
Investor Relations Customer Services
- How can I obtain SEC documents, such as the 10-K or 20-F?
- How can I get information on your key pharmaceutical products?
- How can I get information on the dates Novartis will report sales and earnings?
Can I subscribe to receive Novartis news automatically?
We have a subscription form online where you can register to receive information. Each time something new is published on the investor relations section of our website, you will receive an alert by e-mail. Subscribe to our news
For all other investor relations-related questions
Please contact us at investor relations contacts
For all other share registry-related questions
Please contact us at share registry contact